Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiprodil drug-drug interaction study with CYP and transporter probes
NCT06975605Phase 1Completed
- Sponsor
- GRIN Therapeutics, Inc.
- Start
- May 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of radiprodil, sponsored by GRIN Therapeutics, Inc. Primary endpoints: Area Under the Curve of warfarin at Day 15, Maximum Plasma Concentration of warfarin at Day 15 and 8 more. Started May 2025; status: completed.
02
Drugs
radiprodil
Beyond the preview
Go deeper on NCT06975605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06975605.